https://www.selleckchem.com/pr....oducts/sardomozide-d
dicate a shift in balance towards type I collagen synthesis in HFmrEF compared with HFpEF. Several clinical trials have addressed the therapeutic strategy of adding dipeptidyl peptidase 4 (DPP-4) inhibitors to the treatment of type 2 diabetes mellitus (DM) inadequately controlled by insulin therapy. However, there is a high degree of heterogeneity in these studies, and the cause of which has not been identified. We conducted a meta-analysis of randomized controlled trials, which compared the efficacy and safety of ad
Curtir
Comentario
Compartilhar
